Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)
Sarah Gillessen
◽
Andreas Hüttmann
◽
Vladan Vucinic
◽
Horst Müller
◽
Annette Plütschow
◽
...
2018 ◽
Vol 185
(1)
◽
pp. 42-52
◽
Boris Böll
◽
Annette Plütschow
◽
Carolin Bürkle
◽
Johannes Atta
◽
Michael Pfreundschuh
◽
...
2019 ◽
Vol 3
(S1)
◽
pp. 565
B. von Tresckow
◽
A. Hüttmann
◽
V. Vucinic
◽
H. Mueller
◽
A. Pluetschow
◽
...
2018 ◽
Vol 104
(4)
◽
pp. e151-e153
◽
Anton Hagenbeek
◽
Hans Mooij
◽
Josée Zijlstra
◽
Pieternella Lugtenburg
◽
Gustaaf van Imhoff
◽
...
2018 ◽
Vol 2
(S3)
◽
pp. 53
2019 ◽
Vol 30
(3)
◽
pp. 490-491
P.J. Bröckelmann
◽
H. Müller
◽
E. Kücüksarioglan
◽
P. Kaskel
◽
V. Metterlein
◽
...
Elena Gerhard‐Hartmann
◽
Helen Goergen
◽
Paul J. Bröckelmann
◽
Anja Mottok
◽
Tabea Steinmüller
◽
...
Dennis A. Eichenauer
◽
Horst Müller
◽
Leonard Elger
◽
Helen Goergen
◽
Michael Fuchs
◽
...
P. J. Bröckelmann
◽
H. Müller
◽
S. Gillessen
◽
X. Yang
◽
L. Koeppel
◽
...
D.A. Eichenauer
◽
S. Kreissl
◽
I. Bühnen
◽
C. Baues
◽
C. Kobe
◽
...
2018 ◽
Vol 33
(2)
◽
pp. 439-446
◽
Sven Borchmann
◽
Horst Müller
◽
Heinz Haverkamp
◽
Christian Baues
◽
Jana Marková
◽
...
Close
Export Citation Format
Close
Share Document
Close